HTG Molecular Diagnostics (HTGMQ)
(Delayed Data from OTC)
$0.00 USD
0.00 (0.00%)
Updated Aug 15, 2024 09:31 AM ET
NA Value
NA Growth NA Momentum NA VGMPrice, Consensus and EPS Surprise
HTGMQ 0.00 0.00(0.00%)
Will HTGMQ be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for HTGMQ based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for HTGMQ
Orthofix (OFIX) Q2 Earnings and Revenues Surpass Estimates
TransMedics (TMDX) Reports Q2 Loss, Tops Revenue Estimates
HTGMQ: What are Zacks experts saying now?
Zacks Private Portfolio Services
Integra LifeSciences (IART) Q2 Earnings and Revenues Surpass Estimates